141 related articles for article (PubMed ID: 9236675)
21. Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.
Yuan L; Yao L; Zhao L; Xia L; Shen H; Lu J
Clin Exp Rheumatol; 2013; 31(3):428-32. PubMed ID: 23485578
[TBL] [Abstract][Full Text] [Related]
22. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.
Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G
Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600
[TBL] [Abstract][Full Text] [Related]
23. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
24. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.
Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A
J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
26. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
Chen F; Shu XM; Wang DX; Xie Y; Wang GC
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of soluble interleukin-2 receptor in infectious complications.
Iwagaki H; Hizuta A; Iwadou H; Perdomo JA; Tanaka N; Orita K
Acta Med Okayama; 1994 Aug; 48(4):225-6. PubMed ID: 7817778
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.
Ott M; Demisch L; Engelhardt W; Fischer PA
J Neurol; 1993 Dec; 241(2):108-14. PubMed ID: 8138825
[TBL] [Abstract][Full Text] [Related]
29. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
Weiss M; Martignoni M; Petropoulou T; Sölder B; Belohradsky BH
Infection; 1996; 24(4):301-8. PubMed ID: 8875282
[TBL] [Abstract][Full Text] [Related]
30. Correlation of serum neopterin concentrations with disease activity in juvenile dermatomyositis.
De Benedetti F; De Amici M; Aramini L; Ruperto N; Martini A
Arch Dis Child; 1993 Aug; 69(2):232-5. PubMed ID: 8215528
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis.
Jiang Q; Li Y; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2019 Nov; 39(11):720-725. PubMed ID: 31274382
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
[TBL] [Abstract][Full Text] [Related]
33. Serum C1q Concentration Positively Correlates with Erythrocyte Sedimentation Rate in Polymyositis/Dermatomyositis.
Li L; Chen J; Chen S; Liu C; Zhang F; Li Y
Ann Clin Lab Sci; 2019 Mar; 49(2):237-241. PubMed ID: 31028070
[TBL] [Abstract][Full Text] [Related]
34. Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity.
Suzuki F; Kubota T; Miyazaki Y; Ishikawa K; Ebisawa M; Hirohata S; Ogura T; Mizusawa H; Imai T; Miyasaka N; Nanki T
Arthritis Res Ther; 2012 Mar; 14(2):R48. PubMed ID: 22394569
[TBL] [Abstract][Full Text] [Related]
35. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission.
Shaw CE; Dunbar PR; Macaulay HA; Neale TJ
J Neurol; 1995 Jan; 242(2):53-8. PubMed ID: 7707089
[TBL] [Abstract][Full Text] [Related]
36. [Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits/dermatomyosits].
Chen F; Shu XM; Wang DX; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):204-8. PubMed ID: 22516988
[TBL] [Abstract][Full Text] [Related]
37. [Neopterin: new immunological marker of autoimmune rheumatic disease].
Nasonov EL; Samsonov MIu; Tilz G; Fuchs D
Klin Med (Mosk); 2000; 78(8):43-6. PubMed ID: 11019525
[TBL] [Abstract][Full Text] [Related]
38. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis.
Silva MG; Oba-Shinjo SM; Marie SKN; Shinjo SK
Clin Exp Rheumatol; 2019; 37(4):656-662. PubMed ID: 30620283
[TBL] [Abstract][Full Text] [Related]
39. [Effect of langchuangding on serum soluble interleukin-2 receptor and neopterin level in patients of systemic lupus erythematosus].
Wen CP; Fan YS; Li XM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 May; 21(5):339-41. PubMed ID: 12577416
[TBL] [Abstract][Full Text] [Related]
40. Increased immune activation during and after physical exercise.
Tilz GP; Domej W; Diez-Ruiz A; Weiss G; Brezinschek R; Brezinschek HP; Hüttl E; Pristautz H; Wachter H; Fuchs D
Immunobiology; 1993 Jun; 188(1-2):194-202. PubMed ID: 8104879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
